Viewing Study NCT03391466


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2026-01-05 @ 5:49 PM
Study NCT ID: NCT03391466
Status: COMPLETED
Last Update Posted: 2025-12-01
First Post: 2017-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Kite, A Gilead Company
Organization: